Skip to main content
Clinical Trials/NCT05752240
NCT05752240
Recruiting
Not Applicable

Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias in Patients With Parkinson's Disease.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country32 target enrollmentMarch 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
32
Locations
1
Primary Endpoint
Reduction of dyskinesia
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The main objective of the study is to evaluate the efficacy of 10 sessions of transcranial direct current stimulation of the primary motor cortex to reduce levodopa-induced dyskinesia

Registry
clinicaltrials.gov
Start Date
March 10, 2022
End Date
March 10, 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with diagnosis of idiopathic Parkinson's disease according to Movement Disorder Society (MDS) criteria and levodopa-induced dyskinesia;
  • age between 30 and 80 years;
  • ongoing therapy with levodopa;
  • fulfillment of requirements for the application of transcranial magnetic stimulation (TMS), assessed by completion of the TMS screening questionnaire.

Exclusion Criteria

  • patients unable to give informed consent;
  • cognitive impairment (MMSE ≤ 24);
  • history of epilepsy;
  • pregnant women.

Outcomes

Primary Outcomes

Reduction of dyskinesia

Time Frame: 15 days

Change in the total score of part III of the Unified Dyskinesia Rating Scale (range 0-112, 112 is the worse outcome) in on motor state at the assessment made three days after the end of treatment compared with the assessment made at baseline in the groups of patients treated with tDCS and sham-stimulation, respectively

Study Sites (1)

Loading locations...

Similar Trials